Single User License
INR 170075
Site License
INR 340150
Corporate User License
INR 510225

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Impetigo Global Clinical Trials Review, H1

Impetigo Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Impetigo Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Impetigo Global Clinical Trials Review, H1, 2015" provides an overview of Impetigo clinical trials scenario. This report provides top line data relating to the clinical trials on Impetigo. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Impetigo 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Impetigo to Infectious Disease Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Impetigo to Infectious Disease Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Impetigo 25

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Impetigo Therapeutics Clinical Trials 29

Prominent Drugs 30

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

GlaxoSmithKline Plc 31

Clinical Trial Overview of GlaxoSmithKline Plc 31

NovaBay Pharmaceuticals, Inc. 32

Clinical Trial Overview of NovaBay Pharmaceuticals, Inc. 32

The LEO Foundation 33

Clinical Trial Overview of The LEO Foundation 33

Nestle S.A. 34

Clinical Trial Overview of Nestle S.A. 34

Lytix Biopharma AS 35

Clinical Trial Overview of Lytix Biopharma AS 35

Ferrer Internacional S.A. 36

Clinical Trial Overview of Ferrer Internacional S.A. 36

Foamix Pharmaceuticals Ltd. 37

Clinical Trial Overview of Foamix Pharmaceuticals Ltd. 37

Dermal Laboratories Limited 38

Clinical Trial Overview of Dermal Laboratories Limited 38

Chiltern International Ltd. 39

Clinical Trial Overview of Chiltern International Ltd. 39

Ambria Dermatology AB (Inactive) 40

Clinical Trial Overview of Ambria Dermatology AB (Inactive) 40

Clinical Trial Overview of Top Institutes / Government 41

Menzies School of Health Research 41

Clinical Trial Overview of Menzies School of Health Research 41

Beaumont Health System 42

Clinical Trial Overview of Beaumont Health System 42

Philippine Dermatological Society 43

Clinical Trial Overview of Philippine Dermatological Society 43

Royal North Shore Hospital 44

Clinical Trial Overview of Royal North Shore Hospital 44

University of Texas Health Science Center at Houston 45

Clinical Trial Overview of University of Texas Health Science Center at Houston 45

Five Key Clinical Profiles 46

Appendix 80

Abbreviations 80

Definitions 80

Research Methodology 81

Secondary Research 81

About GlobalData 82

Contact Us 82

Disclaimer 82

Source 82

List of Figures

Impetigo Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Impetigo Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Impetigo Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Impetigo Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Impetigo Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Impetigo Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Impetigo Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Impetigo Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Impetigo to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15

Impetigo Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Impetigo Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Impetigo to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18

Impetigo Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Impetigo Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Impetigo Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Impetigo Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Impetigo Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Impetigo Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Impetigo Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Impetigo Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27

Impetigo Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Impetigo Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Impetigo Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 81

List of Tables

Impetigo Therapeutics, Global, Clinical Trials by Region, 2015* 7

Impetigo Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Impetigo Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Impetigo Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Impetigo Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Impetigo Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Impetigo Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Impetigo Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Impetigo to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15

Impetigo Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Impetigo Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Impetigo to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18

Impetigo Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Impetigo Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Impetigo Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Impetigo Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Impetigo Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Impetigo Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Impetigo Therapeutics, Global, Terminated Clinical Trials, 2015* 25

Impetigo Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Impetigo Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27

Impetigo Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Impetigo Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Impetigo Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 31

Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by NovaBay Pharmaceuticals, Inc., 2015* 32

Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by The LEO Foundation, 2015* 33

Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Nestle S.A., 2015* 34

Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Lytix Biopharma AS, 2015* 35

Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferrer Internacional S.A., 2015* 36

Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Foamix Pharmaceuticals Ltd., 2015* 37

Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Dermal Laboratories Limited, 2015* 38

Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiltern International Ltd., 2015* 39

Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Ambria Dermatology AB (Inactive), 2015* 40

Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Menzies School of Health Research, 2015* 41

Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Beaumont Health System, 2015* 42

Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Philippine Dermatological Society, 2015* 43

Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal North Shore Hospital, 2015* 44

Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Health Science Center at Houston, 2015* 45

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

GlaxoSmithKline Plc

NovaBay Pharmaceuticals, Inc.

The LEO Foundation

Nestle S.A.

Lytix Biopharma AS

Ferrer Internacional S.A.

Foamix Pharmaceuticals Ltd

Dermal Laboratories Limited

Chiltern International Ltd.

Impetigo Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Impetigo, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com